arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ABVC BIOPHARMA, INC.

ABVC

$0.97 ▼ -0.02 (-2.44%) at close

16 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Moderately Bearish

auto_awesome

Analytical Summary

ABVC BIOPHARMA, INC. faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $19.5M

Dividend Yield —

Revenue Growth -41.9% ↘

Op. Margin None

ROIC -64.5% ↗

FCF / Share $-0.15 ↗

Trailing P/E —

Price / Book 2.2x

FCF Yield —

Debt / Equity 0.07

info Valuation on last close. End-of-day price, Nov 5, 2026.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$296.00K

↓ -41.9% —

Net Income Profit after all expenses

$-7.91M

↓ -61.3% —

FCF / Share Free cash flow per share

$-0.15

↑ +4.2% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗
Revenue Growth YoY (%)	-41.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-624%)	234.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2829%)	-84.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1154%)	172.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2057%)	-26.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-429%)	-31.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-490%)	9988.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+124750%)	—	—	—	—	N/M	36.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+353%)	79.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+889%)	—	—
EPS Growth YoY (%)	7.1% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	82.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-367.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-2.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-2.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	66.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-61.3% Weak ↓ Weak Declining Year-over-year change in net income	53.4% Excellent ↑ Excellent Improving Year-over-year change in net income	36.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-27.9% Weak ↑ Weak Improving Year-over-year change in net income	-21.2% Weak ↑ Weak Improving Year-over-year change in net income	-169.3% Weak ↓ Weak Declining Year-over-year change in net income	35.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-42.9% Weak ↑ Weak Improving Year-over-year change in net income	61.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-33999.9% Weak ↓ Weak Declining Year-over-year change in net income	-46015.7% Weak ↓ Weak Declining Year-over-year change in net income	100.0% Excellent ↑ Excellent Improving Year-over-year change in net income	78.8% Excellent Excellent Year-over-year change in net income	12.2% Fair Fair Year-over-year change in net income	—	—
FCF Growth YoY (%)	4.2% Caution ↑ Caution Improving Year-over-year change in free cash flow	84.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-313.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	21.9% Good Good Year-over-year change in free cash flow	-31.3% Weak Weak Year-over-year change in free cash flow	—	—	—	61.1% Excellent Excellent Year-over-year change in free cash flow	N/M	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-32.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	12.7% Good ↓ Good Declining Compound annual revenue growth over 3 years	-31.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	11.4% Good Good Compound annual revenue growth over 3 years	271.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	27.5% Excellent Excellent Compound annual revenue growth over 3 years	—	—	-16.2% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	-9.3% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-6.2% Weak Weak Compound annual revenue growth over 5 years	85.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	170.1% Excellent Excellent Compound annual revenue growth over 5 years	—	-2.2% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	-492.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3386%)	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-5.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-7.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.9% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	5.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—
FCF Margin (%) (%)	—	-355.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	-446.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	100.0% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	-485.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	0.38x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.46x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.32x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.10x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-16.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.17x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.33x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗
Return on Invested Capital (%)	-64.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-375.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-100.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-512.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-142.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-242.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2247.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	46.4% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	235.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	172.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	7.4% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	54.9% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	101.9% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-34.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-62.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-56.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-153.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-85.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-73.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-49.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-46.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-156.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-6200.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-76.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-378.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-511.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-71.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-574%)	—	-125.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-936%)	—	-145.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1068%)	—	—	107.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+615%)	241.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1510%)	172.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1050%)	-111.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-840%)	-0.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-101%)	12.0% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-20%)	65.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+334%)	83.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+455%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗
Debt to Equity (x)	0.07x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-89%)	0.69x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+14%)	0.11x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-82%)	0.61x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.19x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-69%)	0.47x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-21%)	-12.71x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-2218%)	-0.16x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-126%)	—	—	—	—	—	—	—	—
Interest Coverage (x)	-1296.46x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7283.66x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3.30x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-51.42x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-51.52x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-21.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.18x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.02x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-40.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1081.35x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-3.61x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.03x Weak Weak Operating income divided by interest expense Optimal: > 5x	-9.21x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$74.03K	$591.87K	$839.10K	$1.81M	$-4.19M	$-2.64M	$1.77M	$672.56K	$-93.33K	$-173.54K	—	—	$-618.00	$-13.39K	$-71.78K	$-2.81K
Debt / EBITDA (x)	-0.11x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.18x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.11x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.13x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.14x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.19x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.56x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.33x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗
Revenue per Share (USD)	$0.01	$0.04	$0.04	$0.03	$0.01	$0.02	—	—	—	—	$0.00	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.39	$-0.42	$-2.43	$-0.52	$-0.51	$-0.50	—	—	$-0.02	$-0.06	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.15	$-0.15	$-0.98	$-0.24	$-0.30	$-0.23	—	—	$-0.01	$-0.02	$0.00	—	—	—	—	—
Book Value per Share (USD)	$0.44	$0.09	$1.06	$0.09	$0.36	$0.14	$-0.01	$-0.48	$-0.01	$-0.03	$0.00	—	$-0.03	$-0.12	$-0.10	—
Tangible Book Value per Share (USD)	$0.44	$0.09	$1.06	$0.09	$0.36	$0.14	$-0.01	$-0.48	$-0.01	$-0.03	$0.00	—	$-0.03	$-0.12	$-0.10	—
Basic Weighted Avg Shares (shares)	20.11M	11.67M	4.34M	31.66M	25.05M	19.72M	—	—	213.32M	193.98M	5.00M	11,144	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗
Working Capital (USD)	$-3.66M	$-4.38M	$-4.28M	$-2.83M	$3.96M	$1.33M	$-5.94M	$-10.42M	$-1.76M	—	—	—	$-2.11M	$-1.90M	$-1.73M	—
Total Equity (USD)	$11.11M	$1.23M	$8.39M	$3.10M	$8.84M	$3.44M	$-150.96K	$-5.66M	$-1.76M	$-6.38M	$29.08K	$31.36K	$-1.88M	$-1.64M	$-1.46M	$-2.99M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗
Sales/Revenue/Turnover (USD)	$296.00K	$509.59K	$152.43K	$969.78K	$355.80K	$483.05K	$701.72K	$6.96K	—	—	$3.36K	$0.00	$7.79K	$5.71K	$3.19K	—
Depreciation Expense (USD)	$25.33K	$32.02K	$28.53K	$23.80K	$11.99K	$37.14K	$55.09K	$43.61K	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-7.91M	$-4.90M	$-10.52M	$-16.42M	$-12.84M	$-10.59M	$-3.93M	$-6.06M	$-4.24M	$-11.01M	$-32.28K	$-70.00	$-226.35K	$-1.07M	$-1.22M	—
Operating Cash Flow (USD)	$-2.99M	$-1.81M	$-4.24M	$-7.40M	$-7.60M	$-4.56M	$-3.13M	$-900.53K	$-1.49M	$-3.47M	$3.36K	$1.17K	$-37.77K	$-915.12K	$-1.59M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 16 years · 65 quarters

ABVC BIOPHARMA, INC.

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ABVC with peers